Cleared Traditional

K110554 - BIOCERAMIC ORBITAL IMPLANT, ORBTEX

K110554 is an FDA 510(k) clearance for BIOCERAMIC ORBITAL IMPLANT, manufactured by Ceramisys, Ltd.. The device is a Class 2 Ophthalmic device with product code HPZ cleared through the Traditional 510(k) pathway after a 247-day FDA review.

K110554 · Ceramisys, Ltd. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2011
Decision
247d
Days
Class 2
Risk

K110554 is an FDA 510(k) clearance for the BIOCERAMIC ORBITAL IMPLANT, ORBTEX. Classified as Implant, Eye Sphere (product code HPZ), Class II - Special Controls.

Submitted by Ceramisys, Ltd. (Centercille, US). The FDA issued a Cleared decision on November 2, 2011 after a review of 247 days - an extended review cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.3320 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Ceramisys, Ltd. devices

FDA 510(k) Submission Details - K110554

510(k) Number K110554 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 28, 2011
Decision Date November 02, 2011
Days to Decision 247 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
137d slower than avg
Panel avg: 110d · This submission: 247d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HPZ Device Classification - Class 2, Special Controls

Product Code HPZ Implant, Eye Sphere
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.3320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HPZ Implant, Eye Sphere

All 9
Devices cleared under the same product code (HPZ) and FDA review panel - the closest regulatory comparables to K110554.
EZYPOR
K212741 · Fci (France Chirurgie Instrumentation) Sas · Jun 2022
MEDPOR ATTRACTOR IMPLANT
K071335 · Porex Surgical, Inc. · Aug 2007
MEDPOR ATTRACTOR MAGNETIC COUPLING SYSTEM
K040851 · Porex Surgical, Inc. · Jul 2004
MEDPOR PLUS ORBITAL VOLUME REPLACEMENT IMPANT
K021357 · Porex Surgical, Inc. · Aug 2002
MEDPOR QUAD MOTILITY IMPLANT
K010902 · Porex Surgical, Inc. · Jun 2001
GORE SPHEREX IMPLANT
K962241 · W.L. Gore & Associates, Inc. · Aug 1996